Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2861
Selected: 0
NCT IDTitle
NCT01072578A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose
NCT04112498A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab
NCT04472663Participant Reported Outcomes and Treatment Experiences in Kidney Cancer
NCT03192215AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
NCT00754325Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
NCT02420938Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
NCT00627978Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
NCT01511809Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
NCT01498185BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
NCT02632409An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
NCT05671055CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
NCT03547999A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
NCT00258921RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment
NCT00570752Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
NCT00162292Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background
NCT02923934A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
NCT03438279Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy
NCT01754974Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C
NCT00852397A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients
NCT02828124A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer
NCT01063023Drug Interaction Oral Contraceptive Pill (OCP)
NCT00736879Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
NCT02805010Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
NCT05899738A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants
NCT03692325Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
NCT01675076Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
NCT03149120Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
NCT00349518Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
NCT00559247A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects
NCT00357240Drug Interaction Study With Proton Pump Inhibitor
NCT00037089A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
NCT01986218Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors
NCT01404572Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects
NCT01535677To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately
NCT02778906Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
NCT03601611Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
NCT00979316Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects
NCT02864316Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
NCT03225716A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia
NCT05805904A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants
NCT00176267Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
NCT02912234Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
NCT02661516Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists
NCT00337532A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer
NCT04594811NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma
NCT06425198Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
NCT03769558A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
NCT01377935Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
NCT03970252Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT02497508Nivolumab in Patients With Recurrent Malignant Mesothelioma